Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.821 | 2.37e-15 | 5.75e-04 | 3.83e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
TGFB1 | 7040 | 2 | -1.997 | 2.821 | 60 | - | - |
HCFC1 | 3054 | 40 | -2.925 | 3.449 | 71 | Yes | Yes |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
[ AEBP2 ] | 121536 | 1 | -1.218 | 2.821 | 12 | - | - |
PHB2 | 11331 | 5 | -2.236 | 2.994 | 140 | Yes | - |
SUZ12 | 23512 | 2 | -1.792 | 2.904 | 42 | - | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
MED13L | 23389 | 12 | -2.550 | 3.159 | 21 | Yes | - |
SRSF3 | 6428 | 73 | -2.992 | 3.538 | 54 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
YY1 | 7528 | 24 | -2.572 | 3.120 | 114 | Yes | Yes |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
HNRNPU | 3192 | 76 | -2.869 | 3.538 | 139 | Yes | - |
EZH2 | 2146 | 2 | -1.631 | 2.904 | 105 | - | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
EZH2 | 2146 | YY1 | 7528 | pp | -- | int.I2D: BioGrid, BCI |
EZH2 | 2146 | AEBP2 | 121536 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
HCFC1 | 3054 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
EZH2 | 2146 | SUZ12 | 23512 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, BioGrid_Fly, BioGrid_Mouse, IntAct_Mouse, BCI, HPRD, IntAct_Fly; int.Ravasi: -; int.HPRD: in vivo |
SUZ12 | 23512 | AEBP2 | 121536 | pp | -- | int.I2D: BioGrid, BIND, HPRD; int.Ravasi: -; int.HPRD: in vitro |
HNRNPU | 3192 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
EZH2 | 2146 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid |
EZH2 | 2146 | MED13L | 23389 | pp | -- | int.I2D: BioGrid_Fly |
TGFB1 | 7040 | SUZ12 | 23512 | pp | -- | int.I2D: IntAct, SOURAV_MAPK_LOW |
NFRKB | 4798 | YY1 | 7528 | pp | -- | int.I2D: BioGrid |
POU5F1 | 5460 | SRSF3 | 6428 | pp | -- | int.I2D: BioGrid |
HNRNPU | 3192 | YAP1 | 10413 | pp | -- | int.I2D: HPRD; int.HPRD: in vitro, in vivo |
EZH2 | 2146 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid |
PSMD2 | 5708 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0035098 | ESC/E(Z) complex | 3.29e-07 | 4.75e-03 | 7.687 | 3 | 3 | 15 |
GO:0005654 | nucleoplasm | 1.95e-06 | 2.81e-02 | 2.929 | 8 | 64 | 1082 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 8.50e-06 | 1.23e-01 | 3.439 | 6 | 37 | 570 |
GO:0003723 | RNA binding | 1.22e-05 | 1.76e-01 | 3.913 | 5 | 18 | 342 |
GO:0060744 | mammary gland branching involved in thelarche | 1.31e-05 | 1.89e-01 | 8.424 | 2 | 2 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.31e-05 | 1.89e-01 | 8.424 | 2 | 2 | 6 |
GO:0042054 | histone methyltransferase activity | 2.44e-05 | 3.52e-01 | 8.009 | 2 | 3 | 8 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.26e-05 | 4.70e-01 | 3.620 | 5 | 30 | 419 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 4.79e-05 | 6.91e-01 | 7.549 | 2 | 4 | 11 |
GO:0031011 | Ino80 complex | 7.91e-05 | 1.00e+00 | 7.201 | 2 | 6 | 14 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 2.59e-04 | 1.00e+00 | 6.365 | 2 | 4 | 25 |
GO:0044212 | transcription regulatory region DNA binding | 5.14e-04 | 1.00e+00 | 4.201 | 3 | 17 | 168 |
GO:0003714 | transcription corepressor activity | 6.09e-04 | 1.00e+00 | 4.118 | 3 | 11 | 178 |
GO:0043406 | positive regulation of MAP kinase activity | 8.84e-04 | 1.00e+00 | 5.485 | 2 | 2 | 46 |
GO:0005515 | protein binding | 9.66e-04 | 1.00e+00 | 1.037 | 12 | 198 | 6024 |
GO:0014013 | regulation of gliogenesis | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0009817 | defense response to fungus, incompatible interaction | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0010742 | macrophage derived foam cell differentiation | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0045605 | negative regulation of epidermal cell differentiation | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:1901666 | positive regulation of NAD+ ADP-ribosyltransferase activity | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0061035 | regulation of cartilage development | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0060751 | branch elongation involved in mammary gland duct branching | 9.71e-04 | 1.00e+00 | 10.009 | 1 | 1 | 1 |
GO:0009611 | response to wounding | 1.13e-03 | 1.00e+00 | 5.308 | 2 | 5 | 52 |
GO:0003713 | transcription coactivator activity | 1.39e-03 | 1.00e+00 | 3.705 | 3 | 24 | 237 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 1.45e-03 | 1.00e+00 | 5.126 | 2 | 5 | 59 |
GO:0006355 | regulation of transcription, DNA-templated | 1.85e-03 | 1.00e+00 | 2.369 | 5 | 43 | 997 |
GO:0060242 | contact inhibition | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0045066 | regulatory T cell differentiation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0006403 | RNA localization | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0060312 | regulation of blood vessel remodeling | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 2 |
GO:0032943 | mononuclear cell proliferation | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0046732 | active induction of host immune response by virus | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:1901203 | positive regulation of extracellular matrix assembly | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:2000628 | regulation of miRNA metabolic process | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0034696 | response to prostaglandin F | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0043932 | ossification involved in bone remodeling | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0019049 | evasion or tolerance of host defenses by virus | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 2 |
GO:0005634 | nucleus | 2.58e-03 | 1.00e+00 | 1.176 | 10 | 159 | 4559 |
GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0042306 | regulation of protein import into nucleus | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 3 |
GO:0060913 | cardiac cell fate determination | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0002513 | tolerance induction to self antigen | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0070314 | G1 to G0 transition | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 3 |
GO:0010467 | gene expression | 3.16e-03 | 1.00e+00 | 2.623 | 4 | 45 | 669 |
GO:0016363 | nuclear matrix | 3.41e-03 | 1.00e+00 | 4.501 | 2 | 6 | 91 |
GO:0003682 | chromatin binding | 3.49e-03 | 1.00e+00 | 3.241 | 3 | 19 | 327 |
GO:0010936 | negative regulation of macrophage cytokine production | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0051152 | positive regulation of smooth muscle cell differentiation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0060364 | frontal suture morphogenesis | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0046976 | histone methyltransferase activity (H3-K27 specific) | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0010716 | negative regulation of extracellular matrix disassembly | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 4 |
GO:0031536 | positive regulation of exit from mitosis | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0070734 | histone H3-K27 methylation | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 4 |
GO:0043565 | sequence-specific DNA binding | 4.09e-03 | 1.00e+00 | 3.159 | 3 | 11 | 346 |
GO:0003677 | DNA binding | 4.46e-03 | 1.00e+00 | 2.080 | 5 | 49 | 1218 |
GO:0070461 | SAGA-type complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0007182 | common-partner SMAD protein phosphorylation | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 5 |
GO:0042482 | positive regulation of odontogenesis | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0051098 | regulation of binding | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0016202 | regulation of striated muscle tissue development | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0051101 | regulation of DNA binding | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0071168 | protein localization to chromatin | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 5 |
GO:0006325 | chromatin organization | 5.66e-03 | 1.00e+00 | 4.126 | 2 | 12 | 118 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 3 | 6 |
GO:0021695 | cerebellar cortex development | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0085029 | extracellular matrix assembly | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0007435 | salivary gland morphogenesis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0007406 | negative regulation of neuroblast proliferation | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 6 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.71e-03 | 1.00e+00 | 2.904 | 3 | 24 | 413 |
GO:0016574 | histone ubiquitination | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0032930 | positive regulation of superoxide anion generation | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 7 |
GO:0001739 | sex chromatin | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0050765 | negative regulation of phagocytosis | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0007184 | SMAD protein import into nucleus | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0005114 | type II transforming growth factor beta receptor binding | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0032801 | receptor catabolic process | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0045814 | negative regulation of gene expression, epigenetic | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 7 |
GO:0070723 | response to cholesterol | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 7 |
GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0034616 | response to laminar fluid shear stress | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0010763 | positive regulation of fibroblast migration | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0007183 | SMAD protein complex assembly | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 8 |
GO:0010628 | positive regulation of gene expression | 8.55e-03 | 1.00e+00 | 3.819 | 2 | 7 | 146 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 5 | 9 |
GO:0010225 | response to UV-C | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 9 |
GO:0048188 | Set1C/COMPASS complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 9 |
GO:0031065 | positive regulation of histone deacetylation | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 2 | 9 |
GO:0000400 | four-way junction DNA binding | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 1 | 9 |
GO:0006974 | cellular response to DNA damage stimulus | 9.12e-03 | 1.00e+00 | 3.770 | 2 | 7 | 151 |
GO:0006351 | transcription, DNA-templated | 9.29e-03 | 1.00e+00 | 1.833 | 5 | 57 | 1446 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 10 |
GO:0022408 | negative regulation of cell-cell adhesion | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0070306 | lens fiber cell differentiation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 3 | 11 |
GO:0045120 | pronucleus | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 11 |
GO:0008354 | germ cell migration | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 11 |
GO:0032740 | positive regulation of interleukin-17 production | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 1.07e-02 | 1.00e+00 | 3.651 | 2 | 15 | 164 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0043537 | negative regulation of blood vessel endothelial cell migration | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0060389 | pathway-restricted SMAD protein phosphorylation | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0005838 | proteasome regulatory particle | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0019048 | modulation by virus of host morphology or physiology | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 12 |
GO:0005667 | transcription factor complex | 1.21e-02 | 1.00e+00 | 3.558 | 2 | 17 | 175 |
GO:0071480 | cellular response to gamma radiation | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0002028 | regulation of sodium ion transport | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 13 |
GO:0030214 | hyaluronan catabolic process | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0050921 | positive regulation of chemotaxis | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 13 |
GO:0031334 | positive regulation of protein complex assembly | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 13 |
GO:0033280 | response to vitamin D | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 14 |
GO:0030279 | negative regulation of ossification | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 2 | 14 |
GO:0032270 | positive regulation of cellular protein metabolic process | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 14 |
GO:0042307 | positive regulation of protein import into nucleus | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 4 | 15 |
GO:0043011 | myeloid dendritic cell differentiation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0035066 | positive regulation of histone acetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 15 |
GO:0016571 | histone methylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0043981 | histone H4-K5 acetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 5 | 15 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 3 | 15 |
GO:0001824 | blastocyst development | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 5 | 15 |
GO:0060749 | mammary gland alveolus development | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 2 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 16 |
GO:0048535 | lymph node development | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0043274 | phospholipase binding | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0051276 | chromosome organization | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 16 |
GO:0048593 | camera-type eye morphogenesis | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 16 |
GO:0006796 | phosphate-containing compound metabolic process | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 3 | 17 |
GO:0022624 | proteasome accessory complex | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 17 |
GO:0006754 | ATP biosynthetic process | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 18 |
GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 18 |
GO:0071158 | positive regulation of cell cycle arrest | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 2 | 19 |
GO:0043984 | histone H4-K16 acetylation | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 5 | 19 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 3 | 20 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0008156 | negative regulation of DNA replication | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0045596 | negative regulation of cell differentiation | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 20 |
GO:0008380 | RNA splicing | 2.00e-02 | 1.00e+00 | 3.176 | 2 | 22 | 228 |
GO:0007492 | endoderm development | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 21 |
GO:0010575 | positive regulation vascular endothelial growth factor production | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 1 | 21 |
GO:0032967 | positive regulation of collagen biosynthetic process | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 3 | 21 |
GO:0043029 | T cell homeostasis | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 1 | 21 |
GO:0000123 | histone acetyltransferase complex | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 6 | 21 |
GO:0006306 | DNA methylation | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 22 |
GO:0003823 | antigen binding | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0045787 | positive regulation of cell cycle | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 4 | 22 |
GO:0043025 | neuronal cell body | 2.29e-02 | 1.00e+00 | 3.072 | 2 | 9 | 245 |
GO:0000060 | protein import into nucleus, translocation | 2.31e-02 | 1.00e+00 | 5.424 | 1 | 1 | 24 |
GO:0006611 | protein export from nucleus | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 25 |
GO:0031519 | PcG protein complex | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 25 |
GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 3 | 25 |
GO:0035329 | hippo signaling | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 26 |
GO:0071902 | positive regulation of protein serine/threonine kinase activity | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 3 | 26 |
GO:0048565 | digestive tract development | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 2 | 26 |
GO:0030331 | estrogen receptor binding | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 27 |
GO:0071339 | MLL1 complex | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 6 | 27 |
GO:0009314 | response to radiation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 1 | 27 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.63e-02 | 1.00e+00 | 2.964 | 2 | 23 | 264 |
GO:0050714 | positive regulation of protein secretion | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 3 | 28 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.77e-02 | 1.00e+00 | 2.145 | 3 | 39 | 699 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 2.78e-02 | 1.00e+00 | 5.151 | 1 | 2 | 29 |
GO:0030501 | positive regulation of bone mineralization | 2.78e-02 | 1.00e+00 | 5.151 | 1 | 1 | 29 |
GO:0006954 | inflammatory response | 2.87e-02 | 1.00e+00 | 2.895 | 2 | 6 | 277 |
GO:0034644 | cellular response to UV | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 30 |
GO:0042130 | negative regulation of T cell proliferation | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 1 | 30 |
GO:0060325 | face morphogenesis | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 1 | 31 |
GO:0007093 | mitotic cell cycle checkpoint | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 1 | 31 |
GO:0032320 | positive regulation of Ras GTPase activity | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 1 | 32 |
GO:0032570 | response to progesterone | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 1 | 32 |
GO:0043491 | protein kinase B signaling | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:0002062 | chondrocyte differentiation | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 3.06e-02 | 1.00e+00 | 5.009 | 1 | 2 | 32 |
GO:0001837 | epithelial to mesenchymal transition | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 33 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 8 | 33 |
GO:0045599 | negative regulation of fat cell differentiation | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 2 | 35 |
GO:0016592 | mediator complex | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 10 | 35 |
GO:0042552 | myelination | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 4 | 35 |
GO:0001933 | negative regulation of protein phosphorylation | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 36 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 3 | 36 |
GO:0048839 | inner ear development | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 1 | 37 |
GO:0042752 | regulation of circadian rhythm | 3.53e-02 | 1.00e+00 | 4.799 | 1 | 3 | 37 |
GO:0005902 | microvillus | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 3 | 38 |
GO:0001657 | ureteric bud development | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 2 | 38 |
GO:0031490 | chromatin DNA binding | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 2 | 38 |
GO:0097191 | extrinsic apoptotic signaling pathway | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 1 | 38 |
GO:0071407 | cellular response to organic cyclic compound | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 3 | 38 |
GO:0045786 | negative regulation of cell cycle | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 3 | 39 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.78e-02 | 1.00e+00 | 1.970 | 3 | 41 | 789 |
GO:0035019 | somatic stem cell maintenance | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 6 | 40 |
GO:0070301 | cellular response to hydrogen peroxide | 3.91e-02 | 1.00e+00 | 4.651 | 1 | 2 | 41 |
GO:0031124 | mRNA 3'-end processing | 4.00e-02 | 1.00e+00 | 4.616 | 1 | 2 | 42 |
GO:0001047 | core promoter binding | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 5 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 2 | 45 |
GO:0048511 | rhythmic process | 4.28e-02 | 1.00e+00 | 4.517 | 1 | 4 | 45 |
GO:0035064 | methylated histone binding | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 2 | 46 |
GO:0031093 | platelet alpha granule lumen | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 2 | 48 |
GO:0016049 | cell growth | 4.65e-02 | 1.00e+00 | 4.394 | 1 | 3 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 1 | 50 |
GO:0031100 | organ regeneration | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 1 | 50 |
GO:0001948 | glycoprotein binding | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 2 | 50 |
GO:0030334 | regulation of cell migration | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 5 | 50 |
GO:0050680 | negative regulation of epithelial cell proliferation | 4.84e-02 | 1.00e+00 | 4.336 | 1 | 2 | 51 |
GO:0045216 | cell-cell junction organization | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 2 | 54 |
GO:0002244 | hematopoietic progenitor cell differentiation | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 1 | 54 |
GO:0050679 | positive regulation of epithelial cell proliferation | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 2 | 54 |
GO:0008284 | positive regulation of cell proliferation | 5.16e-02 | 1.00e+00 | 2.431 | 2 | 10 | 382 |
GO:0000724 | double-strand break repair via homologous recombination | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 2 | 55 |
GO:0000502 | proteasome complex | 5.49e-02 | 1.00e+00 | 4.151 | 1 | 3 | 58 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 2 | 59 |
GO:0006396 | RNA processing | 5.58e-02 | 1.00e+00 | 4.126 | 1 | 5 | 59 |
GO:0009986 | cell surface | 5.65e-02 | 1.00e+00 | 2.358 | 2 | 9 | 402 |
GO:0006406 | mRNA export from nucleus | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 4 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 5.76e-02 | 1.00e+00 | 4.078 | 1 | 2 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.04e-02 | 1.00e+00 | 4.009 | 1 | 1 | 64 |
GO:0009749 | response to glucose | 6.04e-02 | 1.00e+00 | 4.009 | 1 | 7 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 2 | 65 |
GO:0006310 | DNA recombination | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 7 | 65 |
GO:0010468 | regulation of gene expression | 6.40e-02 | 1.00e+00 | 3.921 | 1 | 2 | 68 |
GO:0006874 | cellular calcium ion homeostasis | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 2 | 70 |
GO:0051897 | positive regulation of protein kinase B signaling | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 2 | 70 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.59e-02 | 1.00e+00 | 3.879 | 1 | 2 | 70 |
GO:0032355 | response to estradiol | 6.68e-02 | 1.00e+00 | 3.859 | 1 | 3 | 71 |
GO:0000165 | MAPK cascade | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 2 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 1 | 72 |
GO:0005796 | Golgi lumen | 6.77e-02 | 1.00e+00 | 3.839 | 1 | 3 | 72 |
GO:0002020 | protease binding | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 6 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.95e-02 | 1.00e+00 | 3.799 | 1 | 2 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 1 | 75 |
GO:0010629 | negative regulation of gene expression | 7.22e-02 | 1.00e+00 | 3.742 | 1 | 4 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 7.31e-02 | 1.00e+00 | 3.723 | 1 | 7 | 78 |
GO:0007565 | female pregnancy | 7.31e-02 | 1.00e+00 | 3.723 | 1 | 2 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 7.40e-02 | 1.00e+00 | 3.705 | 1 | 2 | 79 |
GO:0002576 | platelet degranulation | 7.68e-02 | 1.00e+00 | 3.651 | 1 | 2 | 82 |
GO:0009653 | anatomical structure morphogenesis | 7.77e-02 | 1.00e+00 | 3.634 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 7.77e-02 | 1.00e+00 | 3.634 | 1 | 4 | 83 |
GO:0044822 | poly(A) RNA binding | 7.77e-02 | 1.00e+00 | 1.549 | 3 | 50 | 1056 |
GO:0047485 | protein N-terminus binding | 8.04e-02 | 1.00e+00 | 3.582 | 1 | 3 | 86 |
GO:0050821 | protein stabilization | 8.21e-02 | 1.00e+00 | 3.549 | 1 | 3 | 88 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 1 | 92 |
GO:0001649 | osteoblast differentiation | 8.57e-02 | 1.00e+00 | 3.485 | 1 | 5 | 92 |
GO:0016568 | chromatin modification | 9.11e-02 | 1.00e+00 | 3.394 | 1 | 4 | 98 |
GO:0001934 | positive regulation of protein phosphorylation | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 5 | 104 |
GO:0042127 | regulation of cell proliferation | 1.01e-01 | 1.00e+00 | 3.241 | 1 | 4 | 109 |
GO:0030308 | negative regulation of cell growth | 1.02e-01 | 1.00e+00 | 3.227 | 1 | 6 | 110 |
GO:0030529 | ribonucleoprotein complex | 1.03e-01 | 1.00e+00 | 3.201 | 1 | 5 | 112 |
GO:0072562 | blood microparticle | 1.03e-01 | 1.00e+00 | 3.214 | 1 | 3 | 111 |
GO:0019058 | viral life cycle | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 1 | 115 |
GO:0000209 | protein polyubiquitination | 1.07e-01 | 1.00e+00 | 3.151 | 1 | 3 | 116 |
GO:0007568 | aging | 1.08e-01 | 1.00e+00 | 3.138 | 1 | 2 | 117 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 5 | 124 |
GO:0007050 | cell cycle arrest | 1.14e-01 | 1.00e+00 | 3.055 | 1 | 5 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.17e-01 | 1.00e+00 | 3.009 | 1 | 11 | 128 |
GO:0030335 | positive regulation of cell migration | 1.17e-01 | 1.00e+00 | 3.020 | 1 | 5 | 127 |
GO:0000790 | nuclear chromatin | 1.18e-01 | 1.00e+00 | 2.998 | 1 | 6 | 129 |
GO:0005125 | cytokine activity | 1.26e-01 | 1.00e+00 | 2.900 | 1 | 2 | 138 |
GO:0008083 | growth factor activity | 1.29e-01 | 1.00e+00 | 2.869 | 1 | 3 | 141 |
GO:0005737 | cytoplasm | 1.32e-01 | 1.00e+00 | 0.714 | 6 | 124 | 3767 |
GO:0001666 | response to hypoxia | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 7 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.35e-01 | 1.00e+00 | 2.790 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 4 | 150 |
GO:0005578 | proteinaceous extracellular matrix | 1.45e-01 | 1.00e+00 | 2.687 | 1 | 4 | 160 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.49e-01 | 1.00e+00 | 2.642 | 1 | 12 | 165 |
GO:0030424 | axon | 1.50e-01 | 1.00e+00 | 2.634 | 1 | 4 | 166 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.54e-01 | 1.00e+00 | 2.591 | 1 | 2 | 171 |
GO:0016607 | nuclear speck | 1.55e-01 | 1.00e+00 | 2.582 | 1 | 12 | 172 |
GO:0007049 | cell cycle | 1.56e-01 | 1.00e+00 | 2.566 | 1 | 6 | 174 |
GO:0031625 | ubiquitin protein ligase binding | 1.60e-01 | 1.00e+00 | 2.533 | 1 | 5 | 178 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.65e-01 | 1.00e+00 | 2.485 | 1 | 22 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.69e-01 | 1.00e+00 | 2.446 | 1 | 5 | 189 |
GO:0030168 | platelet activation | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 6 | 205 |
GO:0016071 | mRNA metabolic process | 1.96e-01 | 1.00e+00 | 2.208 | 1 | 8 | 223 |
GO:0005730 | nucleolus | 2.08e-01 | 1.00e+00 | 0.913 | 3 | 66 | 1641 |
GO:0008134 | transcription factor binding | 2.11e-01 | 1.00e+00 | 2.090 | 1 | 18 | 242 |
GO:0016070 | RNA metabolic process | 2.15e-01 | 1.00e+00 | 2.060 | 1 | 8 | 247 |
GO:0016020 | membrane | 2.18e-01 | 1.00e+00 | 0.879 | 3 | 46 | 1681 |
GO:0000166 | nucleotide binding | 2.24e-01 | 1.00e+00 | 1.992 | 1 | 13 | 259 |
GO:0006281 | DNA repair | 2.26e-01 | 1.00e+00 | 1.981 | 1 | 14 | 261 |
GO:0007283 | spermatogenesis | 2.26e-01 | 1.00e+00 | 1.975 | 1 | 3 | 262 |
GO:0043065 | positive regulation of apoptotic process | 2.31e-01 | 1.00e+00 | 1.943 | 1 | 7 | 268 |
GO:0005743 | mitochondrial inner membrane | 2.38e-01 | 1.00e+00 | 1.895 | 1 | 6 | 277 |
GO:0019899 | enzyme binding | 2.38e-01 | 1.00e+00 | 1.895 | 1 | 9 | 277 |
GO:0030198 | extracellular matrix organization | 2.42e-01 | 1.00e+00 | 1.864 | 1 | 6 | 283 |
GO:0042493 | response to drug | 2.43e-01 | 1.00e+00 | 1.859 | 1 | 6 | 284 |
GO:0043234 | protein complex | 2.51e-01 | 1.00e+00 | 1.804 | 1 | 11 | 295 |
GO:0005739 | mitochondrion | 2.52e-01 | 1.00e+00 | 1.046 | 2 | 23 | 998 |
GO:0030154 | cell differentiation | 2.56e-01 | 1.00e+00 | 1.775 | 1 | 5 | 301 |
GO:0008283 | cell proliferation | 2.75e-01 | 1.00e+00 | 1.651 | 1 | 14 | 328 |
GO:0008285 | negative regulation of cell proliferation | 2.93e-01 | 1.00e+00 | 1.545 | 1 | 10 | 353 |
GO:0046982 | protein heterodimerization activity | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 8 | 380 |
GO:0000278 | mitotic cell cycle | 3.20e-01 | 1.00e+00 | 1.398 | 1 | 15 | 391 |
GO:0043066 | negative regulation of apoptotic process | 3.42e-01 | 1.00e+00 | 1.281 | 1 | 16 | 424 |
GO:0007596 | blood coagulation | 3.62e-01 | 1.00e+00 | 1.179 | 1 | 11 | 455 |
GO:0006468 | protein phosphorylation | 3.65e-01 | 1.00e+00 | 1.163 | 1 | 10 | 460 |
GO:0046872 | metal ion binding | 3.67e-01 | 1.00e+00 | 0.657 | 2 | 29 | 1307 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.76e-01 | 1.00e+00 | 1.108 | 1 | 24 | 478 |
GO:0042802 | identical protein binding | 3.80e-01 | 1.00e+00 | 1.090 | 1 | 19 | 484 |
GO:0016032 | viral process | 4.10e-01 | 1.00e+00 | 0.948 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 4.23e-01 | 1.00e+00 | 0.892 | 1 | 12 | 555 |
GO:0042803 | protein homodimerization activity | 4.46e-01 | 1.00e+00 | 0.792 | 1 | 19 | 595 |
GO:0005829 | cytosol | 4.47e-01 | 1.00e+00 | 0.308 | 3 | 86 | 2496 |
GO:0005576 | extracellular region | 6.12e-01 | 1.00e+00 | 0.129 | 1 | 13 | 942 |
GO:0005615 | extracellular space | 6.18e-01 | 1.00e+00 | 0.106 | 1 | 20 | 957 |
GO:0008270 | zinc ion binding | 6.33e-01 | 1.00e+00 | 0.047 | 1 | 27 | 997 |
GO:0070062 | extracellular vesicular exosome | 7.03e-01 | 1.00e+00 | -0.220 | 2 | 57 | 2400 |
GO:0044281 | small molecule metabolic process | 7.07e-01 | 1.00e+00 | -0.233 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 7.33e-01 | 1.00e+00 | -0.333 | 1 | 31 | 1298 |
GO:0005886 | plasma membrane | 9.37e-01 | 1.00e+00 | -1.326 | 1 | 49 | 2582 |